Asensus Surgical, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-12-04: Form 8-K/A; Period of report 2015-09-18; Description 9.01 Financial Statements and Exhibits; Details 9.01.
- 2015-11-16: Form 8-K; Period of report 2015-11-13; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2015-11-09: Form 8-K; Period of report 2015-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-09-21: Form 8-K; Period of report 2015-09-21; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-12-04 | 8-K/A | 2015-09-18 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial Statements of Business Acquired. | d227210d8ka.htm |
| 2015-11-16 | 8-K | 2015-11-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | htm_52732.htm |
| 2015-11-09 | 8-K | 2015-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2015, TransEnterix, Inc., a Delaware corporation (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2015. | htm_52689.htm |
| 2015-09-21 | 8-K | 2015-09-21 | 7.01 Regulation FD Disclosure | 7.01 On September 22, 2015, TransEnterix, Inc. (the “Company”) will hold an investor call to discuss its acquisition from SOFAR S.p.A. of all of the assets, employees and contracts related to the advanced robotic system for minimally invasive laparoscopic surgery known as TELELAP ALF-X. The acquisition closed on September 21, 2015. | d66424d8k.htm |
| 2015-09-21 | 8-K | 2015-09-18 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 2.01 On the Closing Date, pursuant to the Purchase Agreement, the Company completed the strategic acquisition from SOFAR S.p.A. of all of the assets, employees and contracts related to the advanced robotic system for minimally invasive laparoscopic surgery known as TELELAP ALF-X (the “Acquisition Transaction”). 3.02 The issuance of the Securities Consideration as part of the Acquisition Transaction as described under Item 2.01 of this Current Report on Form 8-K, was effected as a private placement of securities and such description is incorporated by reference into this Item 3.02. 5.02 Effective September 21, 2015, the Board of Directors (the “Board”) of the Company elected Andrea Biffi to the Board. | d29233d8k.htm |
| 2015-08-17 | 8-K | 2015-08-14 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information disclosed under Item 1.01 of this Current Report on Form 8-K is incorporated by reference under this Item 2.03. | htm_52305.htm |
| 2015-08-06 | 8-K | 2015-08-06 | 2.02 Results of Operations and Financial Condition | 2.02 On August 6, 2015, TransEnterix, Inc., a Delaware corporation (the "Company") issued a press release announcing its financial results for the second quarter ended June 30, 2015. | htm_52271.htm |
| 2015-07-13 | 8-K | 2015-07-10 | 8.01 Other Events | 8.01 On July 10, 2015, the underwriters of the TransEnterix, Inc. (the "Company") June 2015 public offering of common stock partially exercised the option to purchase additional shares granted to the underwriters to purchase 2,075,000 additional shares of the Company’s common stock at a public offering price of $3.00 per share. | htm_52125.htm |
| 2015-06-12 | 8-K | 2015-06-11 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On June 11, 2015, the Company issued a press release announcing the pricing of the offering of shares of its Common Stock, a copy of which is attached hereto as Exhibit 99.1 and is incorporated by reference herein. | htm_51988.htm |
| 2015-06-08 | 8-K | 2015-06-08 | 8.01 Other Events | 8.01 TransEnterix, Inc. (the “Company”) updated its Company presentation (the “Presentation”) on June 8, 2015. | d938528d8k.htm |
| 2015-06-01 | 8-K | 2015-06-01 | 8.01 Other Events | 8.01 On June 1, 2015, TransEnterix, Inc. (the "Company") announced that it submitted its 510(k) application to the FDA for its SurgiBot™ System. | htm_51929.htm |
| 2015-05-11 | 8-K | 2015-05-07 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On May 7, 2015, TransEnterix, Inc. (the "Company") held its Annual Meeting of Stockholders for 2015 (the "Annual Meeting"). | htm_51802.htm |
| 2015-05-08 | 8-K | 2015-05-07 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On May 7, 2015, TransEnterix, Inc. (the “Company”) held its Annual Meeting of Stockholders for 2015 (the “Annual Meeting”). | htm_51793.htm |
| 2015-05-08 | 8-K | 2015-05-06 | 2.02 Results of Operations and Financial Condition | 2.02 On May 6, 2015, TransEnterix, Inc., a Delaware corporation (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2015. | htm_51792.htm |
| 2015-04-21 | 8-K | 2015-04-17 | 8.01 Other Events | 8.01 On April 17, 2015, TransEnterix, Inc., a Delaware corporation (the “Company”) updated its Company presentation and first used it during an Analyst Investor Event held in Nashville, Tennessee. | d913112d8k.htm |
| 2015-04-16 | 8-K | 2015-04-16 | 8.01 Other Events | 8.01 On April 16, 2015, TransEnterix, Inc. (the "Company") announced the successful completion of its GLP Studies using the SurgiBot system, its patient-side robotic surgery system. | htm_51633.htm |
| 2015-02-26 | 8-K | 2015-02-24 | 2.02 Results of Operations and Financial Condition | 2.02 On February 24, 2015, TransEnterix, Inc., a Delaware corporation (the "Company") issued a press release announcing financial results for the fourth quarter and year ended December, 2014. | htm_51365.htm |
| 2015-02-20 | 8-K | 2015-02-20 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | htm_51334.htm |
| 2015-02-06 | 8-K | 2015-02-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 3, 2015, TransEnterix, Inc. (the "Company"), entered into a new employment agreement (the "Employment Agreement") with Todd M. Pope regarding Mr. Pope’s continued employment with the Company as its President and Chief Executive Officer. | htm_51261.htm |